Under the framework outlined in the LOI, the proposed transaction is informed by an independent third-party valuation of AZIO ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies ...
Nukkleus Inc. (NASDAQ: NUKK) ("Nukkleus" or the "Company"), a strategic acquirer and developer of high-potential businesses in the aerospace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback